Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization

Publication Date

2023

Content Type

Article

PubMed ID:

37722087

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS